AFT’s governance keeps letting it down

AFT’s governance keeps letting it down
Chair David Flacks used to chair NZX’s disciplinary tribunal and governance committee. (Image: AFT)
Jenny Ruth
AFT Pharmaceuticals is a fascinating company that’s been very clever in creating new products from out-of-patent drugs and marketing them in various formats from pills to sachets for hot drinks and intravenous use.The company has an obvious runway to growth globally and founder and managing director Hartley Atkinson is very good at explaining his long-term vision for the company.However, he’s being let down by a board lacking in common sense and good judgement.Certainly, AFT’s chair, David Flacks, ought to know better seeing h...

More Markets

Gentrack sell-off drives NZ sharemarket down
Markets Market Close

Gentrack sell-off drives NZ sharemarket down

The market was down as investors reacted to changing rates from Westpac.

Tom Raynel 10 Dec 2025
Strong early sales for Hallenstein Glasson
Retail

Strong early sales for Hallenstein Glasson

The retailer's growth was primarily driven by the Australian market. 

Jaime Lyth 10 Dec 2025
Australian fund buys stake in AS Colour from Direct Capital
Retail

Australian fund buys stake in AS Colour from Direct Capital

The deal is still conditional and not expected to settle until early 2026.

Jaime Lyth 10 Dec 2025
NZ sharemarket down 0.2%
Markets Market Close

NZ sharemarket down 0.2%

The S&P/NZX 50 closed at 13,454.78, down 31.54 points or 0.23%.

Graham Skellern 09 Dec 2025